GL1X · GenesisL1 explorer

MolNFT v1 · #108808 · protein

Crystal structure of the C89A gmp synthetase inactive mutant from plasmodium falciparum in complex with glutamine

4WIO: “Crystal structure of the C89A gmp synthetase inactive mutant from plasmodium falciparum in complex with…”. X-ray diffraction, 1 ligand (GLN), 6 pockets (best druggability 0.81). MolNFT v1 #108808 on GenesisL1: 3D structure, binding…

PDB
4WIO
Type
protein
Length
525 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gmp synthetase
EC
6.3.5.2
UniProt
Q8IJR9
Ligands
GLN
Pockets
6 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGmp synthetase (EC 6.3.5.2)protein52534% helix, 24% strandQ8IJR9

Ligands and binding sites

  • GLN · Glutamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111530.810.82112empty
22560.580.7829empty
32600.570.7833empty
4750.400.7918GLN
5640.330.7618empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 4WIO · Crystal structure of the C89A GMP synthetase inactive mutant from Plasmodium falciparum… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.